Our services

Pricing & Reimbursement and Market Access

Pricing & Reimbursement

Successful launch is the second major value point in a drug’s life cycle. While market approval is grounded on quality, safety and efficacy, Market Access is contingent upon additionally demonstrating cost-effectiveness to payers. Reimbursement authorities assess the impact of the use of a new drug on healthcare budgets and determine a price, a level of reimbursement, potential limitations in prescribing, as well as consequences of exceeding sales volumes or average daily dose.

RPN services are:

  • Preparation of national Pricing & Reimbursement applications
  • Negotiation with the authorities
  • Coordination of Pricing & Reimbursement applications in EU countries

Market Access

RPN values the importance of understanding clients’ commercial needs, as well as key decision-makers and routes to market. Our analyses work to establish Regulatory and Market Access solutions, which can quicken clients’ products to market, therefore maximising value.

RPN services are:

  • Advice and assistance for compliance with the local requirements
  • Revision of promotional material
  • Assistance in compassionate use and early access programs

Liaison with the regulatory authorities

Assist in developing, assembling, reviewing clients’ meeting request package and initiate contact with agencies. Attend meetings with authorities.

Facilitation of local concerns via a network of partners in EU countries and USA

Consolidated network of partners in EU countries and a local Agent in the USA allow us to support our clients facing specific local issues.